![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 42, 39195-39201, October 18, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, May 24, 2002, and in revised form, July 25, 2002
Methylation of the N-terminal region of histones
was first described more than 35 years ago, but its biological
significance has remained unclear. Proposed functions range from
transcriptional regulation to the higher order packing of chromatin in
progress of mitotic condensation. Primarily because of the recent
discovery of the SET domain-depending H3-specific histone
methyltransferases SUV39H1 and Suv39h1, which selectively methylate
lysine 9 of the H3 N terminus, this posttranslational modification has
regained scientific interest. In the past, investigations concerning
the biological significance of histone methylation were largely limited because of a lack of simple and sensitive analytical procedures for
detecting this modification. The present work investigated the
methylation pattern of histone H4 both in different mammalian organs of
various ages and in cell lines by applying mass spectrometric analysis
and a newly developed hydrophilic-interaction liquid chromatographic
method enabling the simultaneous separation of methylated and
acetylated forms, which obviates the need to work with radioactive
materials. In rat kidney and liver the dimethylated lysine 20 was found
to be the main methylation product, whereas the monomethyl derivative
was present in much smaller amounts. In addition, for the first time a
trimethylated form of lysine 20 of H4 was found in mammalian tissue. A
significant increase in this trimethylated histone H4 was detected in
organs of animals older than 30 days, whereas the amounts of mono- and
dimethylated forms did not essentially change in organs from young (10 days old) or old animals (30 and 450 days old). Trimethylated H4 was also detected in transformed cells; although it was present in only
trace amounts in logarithmically growing cells, we found an increase in
trimethylated lysine 20 in cells in the stationary phase.
In vivo methylation of the side chains of
specific lysines, histidines, and arginines in proteins is a very
common phenomenon in nature involving numerous classes of proteins in
both prokaryotic and eukaryotic cells (1, 2). During the last several
years, studies on the methylation of proteins have yielded many
important observations. While these studies were under way, it was
generally realized that protein methylation is far more complex and has more ramifications than originally assumed.
Methylation is also a well known posttranslational modification
reaction of histone proteins on lysine and/or arginine residues with a
site selectivity for lysine methylation at specific positions in the N
termini of histones H3 and H4. In combination with other posttranslational modifications, i.e. acetylation and
phosphorylation, methylation seems to play a significant role in
regulating nuclear functions. Thus, it has been suggested that distinct
combinations of covalent histone modifications, also referred to as
"histone code," provide a specific mark on the hydrophilic histone
tails, which, when read by other proteins, cause specific downstream events finally inducing transitions in chromatin structure (3, 4).
These chromatin changes are essential prerequisites for important
cellular processes such as transcription, replication, recombination,
etc. In contrast to acetylation and phosphorylation, which represent
short term signals of the histone code, histone methylation is regarded
as a more long term epigenetic mark with a relatively low turnover of
the methyl group (5).
Histone H3 is typically methylated in vivo at lysines 4, 9, and 27 (6) and most probably also at arginine 17 (7). Concerning the
biological significance of H3 methylation, recent papers have shown
that methylation of lysine 4 and arginine 17 is correlated with active
gene expression, whereas lysine 9 methylation is linked to gene
silencing (7-11).
Each of the lysine residues can accept up to three methyl groups
forming mono-, di-, and trimethylated derivatives, thus adding a
further potential complexity to the posttranslational status of histone
H3 (12, 13). The detailed biological role of mono-, di-, and
trimethylation, however, is completely unknown to date.
Histone H4, also a major acceptor of methyl groups, was found to be
methylated at positions 3 (arginine) (14) and 20 (lysine) (2, 15). In
contrast to histone H3 lysine methylation, H4 lysine 20 is described as
being maximally dimethylated in mammals (16). To date, very little is
known about the biological outcome of methylated H4. An increase in H4
methylation has been linked to the termination of liver growth in rats,
and when methylated H4 was found to be present in low amounts in active
chromatin it was proposed that this covalent modification may not be
associated with transcription. A recent paper (17) reported arginine 3 of H4 as the target for methyltransferase PRMT1 in vivo and
in vitro and assigned this specific site an important
function in transcriptional regulation.
To elucidate the biological importance of histone H4 methylation, the
methylation pattern of this core histone was investigated in cells of
various origins. Unlike histone modification by acetylation or
phosphorylation, histone methylation does not greatly influence the
charge of individual amino acids, thus making the electrophoretic separation of distinct methylated proteins from each other and from the
unmethylated parent proteins a problematic part in histone analysis.
Until now, methylated amino acids have often been determined in protein
and tissue hydrolysates using amino acid analyzers and through cells
radiolabeled with [methyl-3H]methionine. To
avoid these labor-intensive and time-consuming methods as well as the
use of radioactivity, a high resolving chromatographic method was
developed for separation and precise quantification of mono-, di-, and
trimethylated H4 histones, including their distinct acetylated forms.
Applying this procedure, we found for the first time in vivo
evidence that lysine 20 of histone H4 is not only mono- and
dimethylated but also trimethylated. A significant increase in this
trimethylated form was observed in rat kidney and liver during aging.
Trimethylated H4 was also detected in small amounts in logarithmically
growing human tumor cells, i.e. Raji and K562. The
proportion of trimethylated histone H4 increased when the cells
were accumulated in the stationary phase. The possible biological
significance of age-related accumulation of trimethylated forms of
histone H4 is discussed in the light of our results.
Materials--
Sodium perchlorate, triethylamine
(TEA),1 acetonitrile (ACN),
and trifluoroacetic acid were purchased from Fluka (Buchs,
Switzerland). All other chemicals were purchased from Merck.
Animals and Tissues--
Rat kidney and liver were obtained from
several Sprague-Dawley rats aged 10, 30, 300, and 450 days.
Cell Cultures--
Raji and K562 cells were cultured in RPMI
1640 medium (Biochrom, Berlin, Germany) supplemented with 10% fetal
calf serum, penicillin (60 µg/ml), and streptomycin (100 µg/ml) in
the presence of 5% CO2. The cells were seeded at a density
of 8 × 104 cells/ml and harvested after 3 days in the
log phase or after 7 days to accumulate the cells in stationary phase.
Preparation of Core Histones--
The core histones were
extracted from organs and cells with sulfuric acid (0.2 M)
according to the procedure of Lindner et al. (18) with
slight modifications. The nuclear pellet was extracted in a first step
with 5% HClO4 (v/v) to remove the H1 histones. In a second
step the pellet was extracted with 1 volume of 0.4 M
H2SO4 and 4 volumes of 0.2 M
H2SO4 for 1 h with occasional vortexing. H2SO4-insoluble material was removed by
centrifugation at 10,000 rpm for 10 min, and soluble proteins were
precipitated by adding trichloroacetic acid to a 20% (w/v) final
concentration. The precipitated core histones were left on ice for 60 min and then centrifuged at 10,000 rpm for 10 min, washed with cold
acidified acetone and with pure acetone, dissolved in 1 ml of water
containing 0.1% 2-mercaptoethanol, lyophilized, and stored at
High Performance Liquid Chromatography--
The equipment used
consisted of a 127 Solvent Module and a model 166 UV-visible region
detector (Beckman Instruments, Palo Alto, CA). The effluent was
monitored at 210 nm, and the peaks were recorded using Beckman System
Gold software. The solvent compositions are expressed as v/v throughout
this text.
Reversed-phase HPLC--
The separation of core histones was
performed on an Ultrapore RPSC C3 column (250 × 10-mm
inner diameter; 5-µm particle pore size; 30-nm pore size; end-capped;
Beckman Instruments). The lyophilized proteins were dissolved in water
containing 0.2 M 2-mercaptoethanol, and samples of ~600
µg were injected onto the column. The histone sample was
chromatographed within 60 min at a constant flow of 1.5 ml/min with a
two-step acetonitrile gradient starting at solvent A-solvent B (60:40)
(solvent A: water containing 0.1% trifluoroacetic acid; solvent B:
70% acetonitrile and 0.1% trifluoroacetic acid). The concentration of
solvent B was increased from 40 to 55% B during 40 min and from 55%
to 100% B during 20 min. The histone H4 fraction was collected and,
after adding 50 µl of 2-mercaptoethanol (0.2 M),
lyophilized and stored at
The peptide samples obtained after digestion of H4 histones by
endoproteinase Glu-C were separated using a Nucleosil 300-5 C18 column (150 × 2-mm inner diameter; 5-µm
particle pore size; end-capped; Macherey-Nagel, Düren, Germany).
Samples of ~100 µg were injected onto the column. Chromatography
was performed within 65 min at a constant flow of 0.15 ml/min with an
acetonitrile gradient starting at solvent A-solvent B (75:25) (solvent
A: water containing 0.1% trifluoroacetic acid; solvent B: 85%
acetonitrile and 0.093% trifluoroacetic acid). The concentration of
solvent B was increased linearly from 25 to 50% during 65 min. The
fractions obtained in this way were collected and, after adding 20 µl
of 2-mercaptoethanol (0.2 M), lyophilized and stored at
Histone H4 peptide fractions obtained by endoproteinase Lys-C cleavage
were injected onto a PepMap C18 column (150 × 1-mm inner diameter; 3-µm particle size; ICT, Vienna, Austria). Samples of
~3 µg were chromatographed within 55 min at a constant flow of 35 µl/min with a two-step acetonitrile gradient starting at solvent
A-solvent B (90:10) (solvent A: water containing 0.1% trifluoroacetic
acid; solvent B: 85% acetonitrile and 0.093% trifluoroacetic acid).
The concentration of solvent B was increased linearly from 10 to 40%
during 45 min and from 40 to 100% during 20 min. The fractions were
collected and, after adding 10 µl of 2-mercaptoethanol (0.2 M), lyophilized and stored at Hydrophilic Interaction Liquid Chromatography--
The histone
fraction H4 (150 µg) isolated by RP-HPLC was further separated on a
SynChropak CM300 column (250 × 4.6-mm inner diameter; 6.5-µm
particle size; 30 nm pore size; Agilent Technologies, Vienna, Austria)
at 30 °C and at a constant flow of 1.0 ml/min using a multi-step
gradient starting at solvent A-solvent B (100:0) (solvent A: 70%
acetonitrile, 0.015 M TEA/H3PO4, pH
3.0; solvent B: 65% acetonitrile, 0.015 M
TEA/H3PO4, pH 3.0 and 0.68 M
NaClO4). The concentration of solvent B was increased from
0 to 10% B during 2 min, from 10 to 40% during 30 min, and then
maintained at 40% during 10 min. The isolated protein fractions were
desalted using RP-HPLC. The histone fractions obtained in this way were
collected and, after adding 20 µl of 2-mercaptoethanol (0.2 M), lyophilized and stored at Endoproteinase Glu-C Digestion--
Whole histone H4 (~100
µg) obtained by RP-HPLC fractionation was digested with
Staphylococcus aureus V8 Protease (Roche Molecular Biochemicals; 1:20 w/w) in 50 µl of 25 mM
NH4HCO3 buffer (pH 4.0) for 1 h at room
temperature. The digest was subjected to RP-HPLC.
Endoproteinase Lys-C Digestion--
N-terminal peptides obtained
by Glu-C digestion were further cleaved with endoproteinase Lys-C
(Roche Molecular Biochemicals; 1:5 w/w) in 15 µl of 25 mM
Tris-HCl buffer (pH 8.7) for 2 h at 37 °C. The digest was
subjected to RP-HPLC.
Amino Acid Sequence Analysis--
Peptide sequencing was
performed on an Applied Biosystems Inc. model 492 Procise protein sequenator.
Mass Spectrometric Analysis--
Determination of the molecular
masses of individual histone H4 peptides obtained after protease digest
was carried out with an electrospray ion-mass spectrometry (ESI-MS)
technique using a Finnigan MAT LCQ ion trap instrument (San Jose, CA).
The samples (5-10 µg) were dissolved in 50% aqueous methanol
containing 0.1% formic acid and injected into the ion source.
HILIC Separation of Acetylated and Methylated Forms of Histone
H4--
Sulfuric acid-extracted core histones were fractionated using
RP-HPLC with a semi-preparative Ultrapore 300-5 C3 column
and a two-step water/acetonitrile gradient. An example, the separation of core histones from rat kidney, is given in Fig.
1A. The identity and purity of
the fractions obtained were checked by means of SDS- and acid-urea-PAGE
(data not shown). The histone H4 fraction eluted at about 41 min as a
single peak despite the presence of a number of distinctly modified
forms. The fact that various posttranslationally modified forms of one
and the same protein coelute in RP-HPLC with its unmodified parent
protein has previously been demonstrated for several histone proteins
(18-20).
Excellent separations of such modified histone proteins, recently
achieved in our laboratory (20-22) and by other groups (23) using
hydrophilic interaction chromatography, prompted us to also evaluate
the potential utility of this technique for the separation of
methylated proteins. Therefore, the histone H4 fraction obtained in the
RP-HPLC run (Fig. 1A) was subjected to HILIC. Under
optimized conditions (pH 3.0 and 30 °C) using a SynChropak CM 300 column with a triethylammonium phosphate buffer system, a linear sodium perchlorate (0-0.68 M), and an inverse acetonitrile
gradient (70-65%), the H4 fraction was separated into two major and
some minor peaks (Fig. 1B).
Characterization of the H4 Subfractions Obtained by HILIC--
In
a first attempt the H4 histone fraction obtained after the initial RP
chromatography (Fig. 1A) was used to localize the domain
responsible for the occurrence of multiple H4 forms in HILIC. For this
purpose the H4 fraction was treated with endoproteinase Glu-C, an
enzyme specifically cleaving proteins under appropriate conditions
C-terminally of glutamic acid. As expected, the fragmentation yielded
several peptides that were separated and isolated by RP-HPLC (Fig.
2). To identify these peptide fractions,
amino acid sequencing and ESI-MS analyses were performed. As
illustrated in Table I, fraction I-II
(eluting at about 60 min) consisted of an H4 peptide ranging from
residues 1 to 63. Fraction III-IV (eluting at 48 min) and fraction IV
(42 min) consisted of C-terminal fragments (residues 64-102 and
75-102, respectively). Fraction II (30 min) was a pure fraction
(residues 54-63), whereas fraction I consisted of two N-terminal
fragments (residues 1-52 and 1-53, respectively). Although the
peptide containing residues 64-74 (designated as peptide III in Table
I) should also be present, it could not be detected. The subsequent
HILIC analysis of the peptide fraction II and fractions III and IV
revealed that both fragments were homogeneous and, consequentially,
excluded as possible sites for H4 modification (data not shown).
Fraction I, however, analyzed by HILIC was heterogeneous and consisted
of several subfractions (Fig. 3;
designated 1'-6'); this chromatogram closely resembled that obtained
by HILIC analysis of undigested H4 shown in Fig. 1B. To
verify that fractions 1'-6' in Fig. 3 indeed correspond to the same
intact forms of the molecule, ESI-MS analyses of peaks 1-6 (Table
II) and fractions 1'-6-' (Table
III) were performed. As can be seen from
Tables II and III, similar mass differences were obtained. This result
clearly indicated that under these chromatographic conditions the same
modifications cause separation of multiple forms and that, furthermore,
the structural alterations must take place in the N-terminal region of
the H4 protein. Identification of peptide fractions 1'-6' is shown in
Table III. Whereas the mass of the blocked N-terminal peptide 1-52 of
histone H4 was calculated to be 5636.7 Da, we found for fractions 6',
5', and 4' significantly higher masses of roughly 14, 28, and 42 Da,
respectively. Because a mass difference of 14 Da corresponds to a
methyl group, we conclude that H4 peptide fragments 6', 5', and 4'
represent mono-, di-, and trimethylated forms, which were clearly
separated under HILIC conditions. Fractions 3', 2', and 1' differed
from 6', 5', and 4' by about 43 Da each, which very well matches with
the mass of an acetyl group. Fractions 1', 2', and 3', therefore, are
the corresponding monoacetylated forms of fractions 4', 5', and 6'. Furthermore, it should be noted that ESI-MS analysis obviously revealed
a contamination of fractions 3' and 6' with another peptide fragment
(Table III). Whereas fraction 6' was contaminated by the prolonged
unacetylated but dimethylated N-terminal peptide 1-53, fraction 3' was
a mixture of the monoacetylated fragments 1-52 (monomethylated) and
1-53 (dimethylated). This finding also easily explains the slight
differences in the relative amounts of HILIC fractions 1'-6' (Fig. 3)
as compared with that of the corresponding undigested H4 fractions
(Fig. 1B).
Evidence for the Presence of Trimethylated Lysine 20 in Histone
H4--
To precisely determine the methylation sites in histone H4,
the HILIC fractions (designated 4'-6') shown in Fig. 3 were isolated and desalted using RP-HPLC. To localize the exact position of the
methyl groups, the N-terminal peptides were further cleaved with
endoproteinase Lys-C. The digests were analyzed by
RP-HPLC-ESI-MS using a 150 × 1.0-mm inner diameter microbore
column. In each case, seven peptide fragments were detected (Table I).
However, only the three fragments 17-31 revealed the mass differences
expected. The peptide derived from fraction 4' exhibited a molecular
mass of 1876.0 Da, that from fraction 5' exhibited a molecular mass of
1861.7 Da, and that from fraction 6' exhibited a molecular mass of
1847.9 Da, indicating that the analyzed fragments were tri-, di-, and
monomethylated. From these data, therefore, a methylation of arginine
3, which is known from the literature (14, 17), can be excluded. To
prove our assumption that lysine 20 is trimethylated and also to
eliminate other arginine and lysine residues present at positions 17, 19, 23, and 31 as possible candidates for methylation, Edman
degradation of the three peptides was carried out (data not shown).
Sequence analysis confirmed that HILIC fraction 6' contained
monomethyllysine, fraction 5' contained dimethyllysine, and fraction 4'
contained trimethyllysine at position 20 of histone H4. Peptide
fragments 3', 2', and 1' are the analogously methylated peptides,
however, bearing an acetyl group. It must be mentioned that in the case
of digestion of the monoacetylated fragments 1-52 (53) the acetyl
group bound to lysine 16 inhibits cleavage at that position. The
cleavage occurs N-terminally of lysine 12, yielding peptides 13-31
having an acetyl group at lysine 16. It should be noted that the
appearance of a trimethylated lysine at position 20 was unexpected,
because in contrast to histone H3, no evidence for a trimethylation of
mammalian H4 has been found to date (24-26).
H4 Methylation Status in Liver and Kidney from Rats of Various
Ages--
To verify that trimethylated histone H4 is not only present
in kidney, H4 was also prepared from rat liver and subjected to HILIC.
The resulting chromatogram (Fig.
4A) closely resembled that
obtained by HILIC analysis of histone H4 from kidney (Fig. 1B), clearly indicating the presence of trimethylated H4 in
this tissue also. Preliminary data of H4 from very young rats, however, indicated a separation pattern (Fig. 4B) different from the
one shown in Fig. 1B. These results prompted us to examine
possible alterations of the H4 methylation status in the course of
aging. For this purpose, liver H4 histones from rats aged 10 days, 30 days, 12 months, and 15 months were isolated and separated by HILIC.
The result clearly showed that trimethylated histone H4 was present in
all samples. Furthermore, no significant change in the relative amount
of dimethylated H4 and only a slight increase in monomethylated H4 was
found in the course of aging. However, a substantial increase in
trimethylated H4 was observed in old rats as compared with young rats.
As can be seen from Fig. 4C, in senescent (450 days old) rat
livers, trimethylation is about 150% higher than in young ones (10 days old). It should be noted, however, that an increase of about 50%
was already observed in the liver of 30-day-old animals. Similar
results were obtained with rat kidney of various ages, although the
age-dependent increase in trimethylation was less prominent
as compared with that in rat liver (Fig.
5). An increase of about 70-80% in rat
kidney versus 150% for liver was observed in older
animals.
H4 Methylation in Human Cell Lines--
Because previous papers
did not report the presence of trimethylated lysine 20 in histone H4
of, for example, HeLa cells (16, 27) or human leukemic cells (28), we
also investigated the extent of H4 methylation in several human cell
lines (Raji, K562) using the HILIC technique. In fact, we found
trimethylated histone H4 in both cell lines. The amount, however, was
very small, especially in logarithmically growing cells, but increased
clearly in nongrowing cells (data not shown).
It has been suggested that distinct combinations of covalent
histone modifications (acetylation, phosphorylation, and methylation), also referred to as the histone code, generate unique surfaces for the
binding of proteins that conduct further chromatin-related processes
responsible for silencing and activating of genes.
Site-specific methylation is catalyzed by conserved proteins known as
the histone methyltransferases (24, 29-31). Histone lysine methylation
has been shown to occur mainly in histones H3 (at lysines 4, 9, and 27)
(6) and H4 (at lysine 20) (29). Whereas acetylation and phosphorylation
on histone N termini represent short term signals of the histone code,
histone methylation has been regarded as a long term epigenetic mark
(5). At present it is unknown how the degree of methyl addition (mono-,
di-, or trimethylation) is increased and whether one and the same
histone methyltransferase is responsible for all of these methyl
additions. The biological significance of the various methyllysine
species also remains unclear. It is known, however, that methyl
addition (mono-, di-, or trimethylation) increases the affinity between histone tails and anionic molecules (i.e. DNA) (32, 33),
whereas acetylation and phosphorylation lead to a loosening of
histone-DNA interactions. Interestingly, in vitro studies
have shown that dimethylation of lysine 9 converts an unmodified H3
N-terminal peptide into a high affinity binding site for HP1 proteins
(9, 10), whereas this high affinity is not significantly affected when
dimethylated lysine 9 is replaced with mono- or trimethylated lysine
(5).
Recent findings suggest that histone H3 methylation of lysine 9 plays a
role in both transcriptional activation and silencing. In this context
it was speculated that the differences in the methylated species of H3
lysine 9 (mono-, di-, or trimethylation) might explain these results,
which at first glance seem to be contradictory (34). The latest
findings by Jacobs et al. (35) and Bannister et
al. (9) concerning methyl-Lys9 H3 binding of HP1
(heterochromatin-associated protein
1), which is necessary for transcriptional repression,
indicate that differences in the extent of methylation (di- or
trimethylation) may result in differences in function. In detail, using
an H3 peptide (residues 1-15) containing both
dimethyl-Lys4 and dimethyl-Lys9 modifications,
Jacobs et al. (35) found in their binding assay with the
chromodomain of HP1 a KD value of 268 µM. Using an H3 peptide (residues 1-16) containing both
trimethyl-Lys4 and trimethyl-Lys9, however,
Bannister et al. (9) reported a dissociation constant KD of 70 nM, a value 1000-fold stronger
than the KD value reported by Jacobs et
al. (35).
At present, little is known about histone H4 methylation. Several
studies have described the occurrence of mono- and dimethyllysine at
lysine 20 in H4 of different species and cell lines (15, 28, 36-38).
Trimethyllysine, however, has been detected only in
Drosophila (39), and not in mammals. Furthermore, many of the earlier observers did not distinguish the individual lysine derivatives or the lysine derivatives from arginine derivatives. This
is due in part to the lack of convenient techniques for their resolution. In contrast to acetylation and phosphorylation, increasing methyl addition does not significantly alter the net positive charge of
the histone molecule, thus limiting the applicability of the
electrophoretic methods (acid-urea and acid-urea-Triton) commonly used
for histone analysis. What does indeed change is the hydrophilicity,
which decreases from mono-, di-, to trimethylation (31). This slightly
altered hydrophilicity enables the HILIC system presented in this paper
to discriminate between the individual modified proteins, because it
separates solutes on the basis of differences in their hydrophilicity,
i.e. the more hydrophilic the solute, the stronger the
interaction with the hydrophilic column material. Therefore,
trimethylated histone H4 is first eluted from the column followed by
the di- and monomethylated forms. In addition to the separation of
methylated H4, the distinctly acetylated derivatives are also clearly
resolved by HILIC. As can be seen from Fig. 1B, lysine
acetylation influences retention to a larger extent than does lysine
methylation. It is possible, therefore, to assign a specific
methylation pattern to each of the differently acetylated H4 histones,
thus enabling the simultaneous analysis of acetylated and methylated
H4. When applying this sensitive and high resolving HILIC method in
combination with mass spectrometry, we found substantial amounts of
trimethylated lysine 20 in H4 of rat liver and kidney, with traces also
being detectable in H4 of human cell lines. Whether the increasing
amounts of trimethylated H4 found in aged tissues ("normal cells")
and in growth-inhibited cell lines ("transformed cells") are
responsible for differences in transcriptional activity is presently
unknown. However, the more pronounced increase in trimethylated H4 in
liver as compared with kidney may be connected to the increased
polyploidization that is characteristic for hepatocytes in aging liver.
Moreover, there is emerging evidence that such a polyploidization leads to growth arrest, terminal differentiation, and tissue maturation (for
review see Ref. 40). It has been reported that the decline of
transcriptional activity is primarily due to changes in the chromatin
structures. The methylation site at lysine 20 in H4 is positioned at
the boundary between the very basic N-terminal tail and the more
hydrophobic domain of the remainder of the molecule, which is folded
within the nucleosome. Methylation at these sites may alter nucleosome
and higher order chromatin structure (41). In any case it is likely
that a histone code proposed for H3 also exists for histone H4
involving methylation (mono-, di-, or trimethylation) of lysine 20, phosphorylation of histidine 18, and acetylation of lysine 16 as well
as methylation of arginine 3 and acetylation of lysine 5 (42).
In summary, our investigations provide the first evidence for in
vivo alterations of a trimethylated lysine of mammalian histone H4
in aging organs. We favor the view that not only methylation in itself
but also the degree of methylation (mono-, di-, or trimethylation) play
a physiologically important role in remodeling chromatin and ultimately
in regulating gene expression.
We are grateful to Dr. H. Dietrich who helped
to obtain rat tissues. We thank A. Devich and S. Gstrein for
excellent technical assistance.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed. Tel.:
43-512-507-3521; Fax: 43-512-507-2876; E-mail:
herbert.lindner@uibk.ac.at.
Published, JBC Papers in Press, August 1, 2002, DOI 10.1074/jbc.M205166200
The abbreviations used are:
TEA, triethylamine;
RP, reversed-phase;
HPLC, high performance liquid chromatography;
HILIC, hydrophilic interaction liquid chromatography;
ESI-MS, electrospray ion mass spectrometry.
Postsynthetic Trimethylation of Histone H4 at Lysine 20 in
Mammalian Tissues Is Associated with Aging*
,
,
¶
Department of Medical Chemistry and
Biochemistry, University of Innsbruck, Fritz-Pregl-Strasse 3, A-6020 Innsbruck, Austria and the § Department of
Biomedicine and Surgery, Division of Cell Biology, Faculty of
Health Sciences, Linköpings Universitet,
SE-581 85 Linköping, Sweden
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 °C until used for HPLC.
20 °C.
20 °C.
20 °C.
20 °C. The peptide
fraction I (~120 µg) obtained by RP-HPLC of endoproteinase Glu-C-
digested H4 histone was further separated by HILIC using the separation
conditions described above.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (20K):
[in a new window]
Fig. 1.
HILIC separation of rat kidney histone H4.
A, sulfuric acid-extracted core histones (~600 µg) from
rat kidney were injected onto an Ultrapore RPSC C3 column
(250 × 10 mm). The histone sample was chromatographed using
RP-HPLC and a two-step acetonitrile gradient starting at 60% A, 40% B
(solvent A, water containing 0.1% trifluoroacetic acid; solvent B,
70% acetonitrile and 0.1% trifluoroacetic acid). The concentration of
solvent B was increased from 40 to 55% B during 40 min and from 55 to
100% B during 20 min. Flow rate was 1.5 ml/min. The protein was
monitored at 210 nm. The histone H4 fraction was collected and, after
adding 50 µl of 2-mercaptoethanol (0.2 M), lyophilized
and stored at
20 °C. B, the histone H4 fraction (150 µg) isolated with RP-HPLC (A) was analyzed on a SynChropak
CM300 column (250 × 4.6 mm) at 30 °C at a constant flow of 1.0 ml/min using a two-step gradient starting at 100% A, 0% B (solvent A:
70% acetonitrile, 0.015 M
TEA/H3PO4, pH 3.0; solvent B: 65%
acetonitrile, 0.015 M TEA/H3PO4, pH
3.0, and 0.68 M NaClO4). The concentration of
solvent B was increased from 0 to 10% B during 2 min, from 10 to 40%
during 30 min, and then maintained at 40% for 10 min. The isolated
protein fractions (designated 1-6) were desalted using RP-HPLC.
Histone fractions obtained in this way were collected and, after adding
20 µl of 2-mercaptoethanol (0.2 M), lyophilized and
stored at
20 °C.

View larger version (19K):
[in a new window]
Fig. 2.
RP-HPLC of peptide fractions of
endoproteinase Glu-C-digested rat kidney H4. Whole histone H4 from
rat kidney isolated with RP-HPLC (Fig. 1A) was digested with
endoproteinase Glu-C as described under "Experimental Procedures."
The digest (containing about 100 µg of peptides) was injected onto a
Nucleosil 300-5 C18 column (150 × 2 mm). Analysis
was performed at a constant flow of 0.15 ml/min using an acetonitrile
gradient starting at 75% A, 25% B (solvent A: water containing 0.1%
trifluoroacetic acid; solvent B: 85% acetonitrile and 0.093%
trifluoroacetic acid). The concentration of solvent B was increased
linearly from 25 to 50% during 65 min. The effluent was monitored at
210 nm. Peptide fractions I, II, I-II, III-IV, and IV were analyzed
using high performance capillary electrophoresis, amino acid sequencing
of the first three amino acids, and ESI-MS (data not shown). Fraction I
was used for HILIC analysis (Fig. 3).
Peptide patterns obtained after endoproteinase Glu-C and Lys-C
digestion of rat kidney histone H4

View larger version (16K):
[in a new window]
Fig. 3.
HILIC separation of peptide fraction I
obtained with RP-HPLC of endoproteinase Glu-C-digested rat H4
histone. The sample (~120 µg) was analyzed on a SynChropak
CM300 column (250 × 4.6 mm) under the same conditions as
described for Fig. 1B. The HILIC fractions (designated
1'-6') were desalted using RP-HPLC. The peptide fractions obtained in
this way were collected and applied on an electrospray
mass-spectrometer (Table III).
ESI-MS data of peaks 1-6 (Fig. 1B)
ESI-MS data of peaks 1'-6' (Fig. 3)

View larger version (15K):
[in a new window]
Fig. 4.
HILIC separation of rat liver histone H4 of
young (10 days old) and old (450 days old) animals and age dependence
of the different methylated histone H4 forms. A and
B, histone H4 fractions (~150 µg) obtained from liver of
rats aged 450 days (A) and from liver of rats aged 10 days
(B) were isolated using RP-HPLC and analyzed under the same
HILIC conditions used in Fig. 1B. C, age dependence of the
different methylated histone H4 forms (H4ac0 + H4ac1) from liver of rats aged 10, 30, 300, and 450 days
was determined. The amount of each H4 modification was quantified using
Beckman System Gold Software. The relative increase in H4
trimethylation of 30-, 300-, and 450-day-old rats was compared with the
10-day values (0%). The results represent the means ± S.D. for
three to five independent experiments.

View larger version (38K):
[in a new window]
Fig. 5.
Age dependence of the trimethylated histone
H4 forms in rat liver and kidney. H4 was obtained from liver and
kidney of rats aged 10, 30, 300, and 450 days. The H4 fractions (~150
µg) isolated with RP-HPLC were analyzed under the same HILIC
conditions used in Fig. 1B. The amount of trimethylated H4
was quantified using Beckman System Gold Software. The relative
increase in H4 trimethylation of 30-, 300-, and 450-day-old rats was
compared with the 10-day values (0%). The results represent the
means ± S.D. for three to five independent experiments.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Paik, W. K., and K. S. (1980) Protein
Methylation, John Wiley & Sons, New York
2.
Wold, F.
(1981)
Annu. Rev. Biochem.
50,
783-814[CrossRef][Medline]
[Order article via Infotrieve]
3.
Strahl, B. D.,
and Allis, C. D.
(2000)
Nature
403,
41-45[CrossRef][Medline]
[Order article via Infotrieve]
4.
Turner, B. M.
(2000)
Bioessays
22,
836-845[CrossRef][Medline]
[Order article via Infotrieve]
5.
Jenuwein, T.
(2001)
Trends Cell Biol.
11,
266-273[CrossRef][Medline]
[Order article via Infotrieve]
6.
DeLange, R. J,
Smith, D. L.,
and Bonner, J.
(1970)
Biochem. Biophys. Res. Commun.
40,
989-993[CrossRef][Medline]
[Order article via Infotrieve]
7.
Bauer, U. M.,
Daujat, S.,
Nielsen, S. J.,
Nightingale, K.,
and Kouzarides, T.
(2002)
EMBO Rep.
3,
39-44[CrossRef][Medline]
[Order article via Infotrieve]
8.
Boggs, B. A.,
Cheung, P.,
Heard, E.,
Spector, D. L.,
Chinault, A. C.,
and Allis, C. D.
(2002)
Nat. Genet.
30,
73-76[CrossRef][Medline]
[Order article via Infotrieve]
9.
Bannister, A. J.,
Zegerman, P.,
Partridge, J. F.,
Miska, E. A.,
Thomas, J. O.,
Allshire, R. C.,
and Kouzarides, T.
(2001)
Nature
410,
120-124[CrossRef][Medline]
[Order article via Infotrieve]
10.
Lachner, M.,
O'Carroll, D.,
Rea, S.,
Mechtler, K.,
and Jenuwein, T.
(2001)
Nature
410,
116-120[CrossRef][Medline]
[Order article via Infotrieve]
11.
Chen, D., Ma, H.,
Hong, H.,
Koh, S. S.,
Huang, S. M.,
Schurter, B. T.,
Aswad, D. W.,
and Stallcup, M. R.
(1999)
Science
284,
2174-2177 12.
Wu, R. S.,
Panusz, H. T.,
Hatch, C. L.,
and Bonner, W. M.
(1986)
CRC Crit. Rev. Biochem.
20,
201-263[Medline]
[Order article via Infotrieve]
13.
Sung, M. T.,
Harford, J.,
Bundman, M.,
and Vidalakis, G.
(1977)
Biochemistry
16,
279-285[CrossRef][Medline]
[Order article via Infotrieve]
14.
Strahl, B. D.,
Briggs, S. D.,
Brame, C. J.,
Caldwell, J. A.,
Koh, S. S., Ma, H.,
Cook, R. G.,
Shabanowitz, J.,
Hunt, D. F.,
Stallcup, M. R.,
and Allis, C. D.
(2001)
Curr. Biol.
11,
996-1000[CrossRef][Medline]
[Order article via Infotrieve]
15.
Strahl, B. D.,
Ohba, R.,
Cook, R. G.,
and Allis, C. D.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14967-14972 16.
Annunziato, A. T.,
Eason, M. B.,
and Perry, C. A.
(1995)
Biochemistry
34,
2916-2924[CrossRef][Medline]
[Order article via Infotrieve]
17.
Wang, H.,
Huang, Z. Q.,
Xia, L.,
Feng, Q.,
Erdjument-Bromage, H.,
Strahl, B. D.,
Briggs, S. D.,
Allis, C. D.,
Wong, J.,
Tempst, P.,
and Zhang, Y.
(2001)
Science
293,
853-857 18.
Lindner, H.,
Helliger, W.,
Dirschlmayer, A.,
Jaquemar, M.,
and Puschendorf, B.
(1992)
Biochem. J.
283,
467-471[Medline]
[Order article via Infotrieve]
19.
Lindner, H.,
Helliger, W.,
Dirschlmayer, A.,
Talasz, H.,
Wurm, M.,
Sarg, B.,
Jaquemar, M.,
and Puschendorf, B.
(1992)
J. Chromatogr.
608,
211-216[CrossRef][Medline]
[Order article via Infotrieve]
20.
Lindner, H.,
Sarg, B.,
Hoertnagl, B.,
and Helliger, W.
(1998)
J. Biol. Chem.
273,
13324-13330 21.
Lindner, H.,
Sarg, B.,
Meraner, C.,
and Helliger, W.
(1996)
J. Chromatogr.
743,
137-144[CrossRef][Medline]
[Order article via Infotrieve]
22.
Lindner, H.,
Sarg, B.,
and Helliger, W.
(1997)
J. Chromatogr.
782,
55-62[CrossRef][Medline]
[Order article via Infotrieve]
23.
Mizzen, C. A.,
Alpert, A. J.,
Levesque, L.,
Kruck, T. P.,
and McLachlan, D. R.
(2000)
J. Chromatogr.
744,
33-46[Medline]
[Order article via Infotrieve]
24.
Duerre, J. A.,
and Onisk, D. V.
(1985)
Biochim. Biophys. Acta
843,
58-67[Medline]
[Order article via Infotrieve]
25.
Thomas, G.,
Lange, H. W.,
and Hempel, K.
(1975)
Eur. J. Biochem.
51,
609-615[Medline]
[Order article via Infotrieve]
26.
Hempel, K.,
Thomas, G.,
Roos, G.,
Stocker, W.,
and Lange, H. W.
(1979)
Hoppe-Seyler's Z. Physiol. Chem.
360,
869-876[Medline]
[Order article via Infotrieve]
27.
Borun, T. W.,
Pearson, D.,
and Paik, W. K.
(1972)
J. Biol. Chem.
247,
4288-4298 28.
Desai, L. S.,
and Foley, G. E.
(1970)
Biochem. J.
119,
165-170[Medline]
[Order article via Infotrieve]
29.
Sarnow, P.,
Rasched, I.,
and Knippers, R.
(1981)
Biochim. Biophys. Acta
655,
349-358[Medline]
[Order article via Infotrieve]
30.
Paik, W. K.,
and Kim, S.
(1969)
Arch. Biochem. Biophys.
134,
632-637[CrossRef][Medline]
[Order article via Infotrieve]
31.
Paik, W. K.,
and Kim, S.
(1971)
Science
174,
114-119 32.
Baxter, C. S.,
and Byvoet, P.
(1975)
Biochem. Biophys. Res. Commun.
63,
286-291[CrossRef][Medline]
[Order article via Infotrieve]
33.
Byvoet, P.,
Shepherd, G. R.,
Hardin, J. M.,
and Noland, B. J.
(1972)
Arch. Biochem. Biophys.
148,
558-567[CrossRef][Medline]
[Order article via Infotrieve]
34.
Rice, J. C.,
and Allis, C. D.
(2001)
Curr. Opin. Cell Biol.
13,
263-273[CrossRef][Medline]
[Order article via Infotrieve]
35.
Jacobs, S. A.,
Taverna, S. D.,
Zhang, Y.,
Briggs, S. D., Li, J.,
Eissenberg, J. C.,
Allis, C. D.,
and Khorasanizadeh, S.
(2001)
EMBO J.
20,
5232-5241[CrossRef][Medline]
[Order article via Infotrieve]
36.
Honda, B. M.,
Dixon, G. H.,
and Candido, E. P.
(1975)
J. Biol. Chem.
250,
8681-8685 37.
Ogawa, Y.,
Quagliarotti, G.,
Jordan, J.,
Taylor, C. W.,
Starbuck, W. C.,
and Busch, H.
(1969)
J. Biol. Chem.
244,
4387-4392 38.
Starbuck, W. C.,
Mauritzen, C. M.,
Taylor, C. W.,
Saroja, I. S.,
and Busch, H.
(1968)
J. Biol. Chem.
243,
2038-2047 39.
Desrosiers, R.,
and Tanguay, R. M.
(1988)
J. Biol. Chem.
263,
4686-4692 40.
Gupta, S.
(2000)
Semin. Cancer Biol.
10,
161-171[CrossRef][Medline]
[Order article via Infotrieve]
41.
Hendzel, M. J.,
and Davie, J. R.
(1989)
J. Biol. Chem.
264,
19208-19214 42.
Jenuwein, T.,
and Allis, C. D.
(2001)
Science
293,
1074-1080 43.
Grimes, S.,
Weisz-Carrington, P.,
Daum, H., III,
Smith, J.,
Green, L.,
Wright, K.,
Stein, G.,
and Stein, J.
(1987)
Exp. Cell Res.
173,
534-545[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
G. Schotta, R. Sengupta, S. Kubicek, S. Malin, M. Kauer, E. Callen, A. Celeste, M. Pagani, S. Opravil, I. A. De La Rosa-Velazquez, et al. A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse Genes & Dev., August 1, 2008; 22(15): 2048 - 2061. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Pesavento, C. R. Bullock, R. D. LeDuc, C. A. Mizzen, and N. L. Kelleher Combinatorial Modification of Human Histone H4 Quantitated by Two-dimensional Liquid Chromatography Coupled with Top Down Mass Spectrometry J. Biol. Chem., May 30, 2008; 283(22): 14927 - 14937. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sakaguchi, D. Karachentsev, M. Seth-Pasricha, M. Druzhinina, and R. Steward Functional Characterization of the Drosophila Hmt4-20/Suv4-20 Histone Methyltransferase Genetics, May 1, 2008; 179(1): 317 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Pesavento, H. Yang, N. L. Kelleher, and C. A. Mizzen Certain and Progressive Methylation of Histone H4 at Lysine 20 during the Cell Cycle Mol. Cell. Biol., January 1, 2008; 28(1): 468 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Pesavento, B. A. Garcia, J. A. Streeky, N. L. Kelleher, and C. A. Mizzen Mild Performic Acid Oxidation Enhances Chromatographic and Top Down Mass Spectrometric Analyses of Histones Mol. Cell. Proteomics, September 1, 2007; 6(9): 1510 - 1526. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. FRAGA, R. AGRELO, and M. ESTELLER Cross-Talk between Aging and Cancer: The Epigenetic Language Ann. N.Y. Acad. Sci., April 1, 2007; 1100(1): 60 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Shumaker, T. Dechat, A. Kohlmaier, S. A. Adam, M. R. Bozovsky, M. R. Erdos, M. Eriksson, A. E. Goldman, S. Khuon, F. S. Collins, et al. From the Cover: Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging PNAS, June 6, 2006; 103(23): 8703 - 8708. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boix-Chornet, M. F. Fraga, A. Villar-Garea, R. Caballero, J. Espada, A. Nunez, J. Casado, C. Largo, J. I. Casal, J. C. Cigudosa, et al. Release of Hypoacetylated and Trimethylated Histone H4 Is an Epigenetic Marker of Early Apoptosis J. Biol. Chem., May 12, 2006; 281(19): 13540 - 13547. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sarg, W. Helliger, H. Talasz, B. Forg, and H. H. Lindner Histone H1 Phosphorylation Occurs Site-specifically during Interphase and Mitosis: IDENTIFICATION OF A NOVEL PHOSPHORYLATION SITE ON HISTONE H1 J. Biol. Chem., March 10, 2006; 281(10): 6573 - 6580. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Talasz, H. H. Lindner, B. Sarg, and W. Helliger Histone H4-Lysine 20 Monomethylation Is Increased in Promoter and Coding Regions of Active Genes and |